Cargando…
Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE)
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung injury with high mortality; no approved medication exists. Efficacy and safety of bone marrow–derived, allogeneic, multipotent adult progenitor cells (invimestrocel) plus standard treatment in patients wit...
Autores principales: | Ichikado, Kazuya, Kotani, Toru, Kondoh, Yasuhiro, Imanaka, Hideaki, Johkoh, Takeshi, Fujimoto, Kiminori, Nunomiya, Shin, Kawayama, Tomotaka, Sawada, Masanori, Jenkins, Eric, Tasaka, Sadatomo, Hashimoto, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464414/ https://www.ncbi.nlm.nih.gov/pubmed/37608287 http://dx.doi.org/10.1186/s13287-023-03451-z |
Ejemplares similares
-
Clinical characteristics and prognosis of drug-associated acute respiratory distress syndrome compared with non-drug-associated acute respiratory distress syndrome: a single-centre retrospective study in Japan
por: Anan, Keisuke, et al.
Publicado: (2017) -
ARDS Clinical Practice Guideline 2021
por: Tasaka, Sadatomo, et al.
Publicado: (2022) -
Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia
por: Ichikado, Kazuya, et al.
Publicado: (2021) -
An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)
por: Ichikado, Kazuya, et al.
Publicado: (2023) -
Overexpression of Chitinase 3-Like 1/YKL-40 in Lung-Specific IL-18-Transgenic Mice, Smokers and COPD
por: Sakazaki, Yuki, et al.
Publicado: (2011)